Rebecca Lynch
@RebeccaLynchLab
Followers
66
Following
14
Media
6
Statuses
20
Associate Professor @GWSMHS. Lynch Lab investigates antibody responses to virus infection and the use of monoclonal antibodies as therapeutics to combat HIV.
George Washington University
Joined November 2020
Our #GWIBSFamily PhD student Teresa Murphy is a natural on the big stage! #HIVResearch #PresentationProps 👩🏾🏫
Congrats to Teresa for presenting her research at the HIV DRP Think Tank Meeting at the National Cancer Institute!!
0
2
6
Some of our lab members are enjoying their newfound fame!
0
2
7
Congrats to all of our lab members who presented at the 2024 SMHS Research Showcase! We are so proud!
0
2
5
Congrats to Teresa for presenting her research at the HIV DRP Think Tank Meeting at the National Cancer Institute!!
0
1
6
Spotted members of @RebeccaLynchLab representing scientific innovation on the @GWtweets Foggy Bottom-Mt. Vernon campus shuttle!
0
2
12
Bit of a side project🤷♀️ But congrats to Andrew for getting me to get his second paper out!! Probiotic Therapy During Vaccination Alters Antibody Response to Simian-Human Immunodeficiency Virus Infection But Not to Commensals
0
1
4
Congrats Michelle on our new publication! Antibody and T-cell responses to COVID-19 Vaccination in Common Variable Immunodeficiency and Specific Antibody Deficiency
annallergy.org
Clinical trials of the mRNA coronavirus disease 2019 (COVID-19) vaccines excluded individuals with primary antibody deficiencies.
0
1
4
They grow up!! Congratulations Dr Wilson! My first graduate student to defend 🎉
1
0
9
Characterizing the Relationship Between Neutralization Sensitivity and env Gene Diversity During ART Suppression https://t.co/NsZl507FWs Congratulations Andrew - first graduate student publication😍🎉
1
3
17
Trying to keep the virus shedder from attacking the computer... Does working from home make our lives easier?#sciencemom
2
0
7
What are the selective pressures on HIV longitudinally during the course of infection? Elegant paper from B Hahn and K Bar demonstrating type 1 IFNs' restriction on virus after transmission and during virus rebound after analytical treatment interruption https://t.co/BCcjb5qgQk
0
0
2
Important paper in @NEJM describing clinical data on which HIV strains can be prevented from transmitting when an antibody is used as a prevention method. Unsurprising but moving the antibody field forward! https://t.co/RVRBtYrwR9
nejm.org
Whether a broadly neutralizing antibody (bnAb) can be used to prevent human immunodeficiency virus type 1 (HIV-1) acquisition is unclear. We enrolled at-risk cisgender men and transgender persons i...
0
0
2
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates https://t.co/H5mWdpYquz
@MHRPInfo @wrair @HJFMilMed @kanekiyom
biorxiv.org
The emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants stresses the continued need for next-generation vaccines that confer broad protection against coronavirus...
1
6
17
Check out our newest paper! We are excited to share our findings in @NatureComms on HIV-1 reservoir diversity quantification using the Intact Proviral DNA Assay (IPDA). https://t.co/bOnyD6rNXi
nature.com
Nature Communications - The intact proviral DNA assay quantifies the genomically intact HIV reservoir, but assay failure due to HIV-1 polymorphism has been observed. Here, the authors report a 28%...
1
0
5
HOT 👏🏼 OFF 👏🏼 THE 👏🏼 PRESS 👏🏼 Check out our newest paper in @ImmunityCP! https://t.co/WeR74wfyOO
3
13
81
@hjf @wrair @armyfutures @ccp4_mx @NIH Structural Biology at EIDB/WRAIR is hiring for a lab manager and two postdoctoral fellows to work on COVID-19 and Emerging Infectious Diseases leveraging structural biology to develop novel vaccines and therapeutics.
2
3
4
Congratulations Andrew on your first review paper! Embracing diversity: how can broadly neutralizing antibodies effectively target a diverse HIV-1... - https://t.co/iTi8w5Gz7p
#ScholarAlerts
0
3
4